Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125426101 | 12542610 | 1 | I | 20160603 | 20160709 | 20160709 | PER | US-JNJFOC-20160604135 | JANSSEN | 29.00 | YR | M | Y | 0.00000 | 20160709 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125426101 | 12542610 | 1 | SS | INVEGA SUSTENNA | PALIPERIDONE PALMITATE | 1 | Intramuscular | N | UNKNOWN;UNKNOWN | 0 | 234 | MG | INJECTION | ||||||
| 125426101 | 12542610 | 2 | SS | INVEGA SUSTENNA | PALIPERIDONE PALMITATE | 1 | Intramuscular | N | UNKNOWN;UNKNOWN | 0 | 156 | MG | INJECTION | ||||||
| 125426101 | 12542610 | 3 | PS | INVEGA SUSTENNA | PALIPERIDONE PALMITATE | 1 | Intramuscular | N | UNKNOWN;UNKNOWN | 22264 | 234 | MG | INJECTION | /month | |||||
| 125426101 | 12542610 | 4 | C | INVEGA | PALIPERIDONE | 1 | Oral | 0 | 12 | MG | OROS (ORAL OSMOTIC) THERAPEUTIC SYSTEM TABLET | ||||||||
| 125426101 | 12542610 | 5 | C | QUETIAPINE. | QUETIAPINE | 1 | Unknown | 0 | 50 | MG | UNSPECIFIED | ||||||||
| 125426101 | 12542610 | 6 | C | LAMOTRIGINE. | LAMOTRIGINE | 1 | Unknown | 0 | 300 | MG | UNSPECIFIED | ||||||||
| 125426101 | 12542610 | 7 | C | LAMOTRIGINE. | LAMOTRIGINE | 1 | Unknown | 0 | 200 | MG | UNSPECIFIED | ||||||||
| 125426101 | 12542610 | 8 | C | CLONIDINE. | CLONIDINE | 1 | Unknown | 0 | .2 | MG | UNSPECIFIED | ||||||||
| 125426101 | 12542610 | 9 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Unknown | 0 | 50 | MG | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125426101 | 12542610 | 1 | Schizoaffective disorder |
| 125426101 | 12542610 | 2 | Schizoaffective disorder |
| 125426101 | 12542610 | 3 | Schizoaffective disorder |
| 125426101 | 12542610 | 4 | Product used for unknown indication |
| 125426101 | 12542610 | 5 | Product used for unknown indication |
| 125426101 | 12542610 | 6 | Product used for unknown indication |
| 125426101 | 12542610 | 7 | Product used for unknown indication |
| 125426101 | 12542610 | 8 | Product used for unknown indication |
| 125426101 | 12542610 | 9 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125426101 | 12542610 | Anger | |
| 125426101 | 12542610 | Drug ineffective | |
| 125426101 | 12542610 | Malaise | |
| 125426101 | 12542610 | Overweight | |
| 125426101 | 12542610 | Poor quality sleep |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |